Firms/companies
Supreme Court holds Monsanto’s patent on GM cotton seeds valid in India
08 Jan 2019
For Monsanto, now owned by German pharma and life sciences major Bayer AG, the apex court ruling involving its business in the world’s biggest producer of the fiber comes as a rare victory
Some Facebook users perceive worsening physical health
08 Jan 2019
In the first study of its kind reveals Facebook use is linked to perceptions of worsening physical health, new research from the University of Surrey, reports
HAL gets nod to produce weaponised version of LCA Tejas
04 Jan 2019
The Centre for Military Airworthiness and Certification (CEMILAC) has given the final operational clearance to start manufacturing of the weaponised Tejas Mk1, while the actual final operational clearance will take place only after extensive tests and trial
HAL gets nod to produce weaponised version of LCA Tejas
04 Jan 2019
The Centre for Military Airworthiness and Certification (CEMILAC) has given the final operational clearance to start manufacturing of the weaponised Tejas Mk1, while the actual final operational clearance will take place only after extensive tests and trial
HAL gets nod to produce weaponised version of LCA Tejas
04 Jan 2019
The Centre for Military Airworthiness and Certification (CEMILAC) has given the final operational clearance to start manufacturing of the weaponised Tejas Mk1, while the actual final operational clearance will take place only after extensive tests and trial
Nestle admits to lead content in its Maggi noodles
04 Jan 2019
The Supreme Court has, however, directed that the reports received from the Central Food Technological Research Institute will be the basis for proceedings before the National Consumer Disputes Redressal Commission
Apple acknowledges waning demand for iPads and iPhones
03 Jan 2019
Hit by falling Chinese sales, Apple on Wednesday revised its revenue guidance for its fiscal 2019 first quarter ended on 29 December to approximately $84 billion, with other income of approximately $550 million
Bristol-Myers to acquire Celgene in $74-bn cash-and-stock deal
03 Jan 2019
Celgene shareholders will receive one Bristol-Myers Squibb share and $50 in cash for each share held, or $102.43 per share, a premium of 53.7 per cent to Celgene’s Wednesday close, besides one tradable contingent value right for each share held
Bristol-Myers to acquire Celgene in $74-bn cash-and-stock deal
03 Jan 2019
Celgene shareholders will receive one Bristol-Myers Squibb share and $50 in cash for each share held, or $102.43 per share, a premium of 53.7 per cent to Celgene’s Wednesday close, besides one tradable contingent value right for each share held
Cabinet nod for merger of Vijaya Bank and Dena Bank into Bank of Baroda
02 Jan 2019
The merger will combine the advantages of Dena Bank's relatively higher access to low-cost CASA deposits, Vijaya Bank's profitability and availability of capital for growth, and the extensive and global network and offerings of BoB
Cabinet nod for merger of Vijaya Bank and Dena Bank into Bank of Baroda
02 Jan 2019
The merger will combine the advantages of Dena Bank's relatively higher access to low-cost CASA deposits, Vijaya Bank's profitability and availability of capital for growth, and the extensive and global network and offerings of BoB